IRIS
CHIMENTI, SERGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 46.867
AS - Asia 6.241
EU - Europa 5.697
SA - Sud America 791
AF - Africa 154
OC - Oceania 53
Continente sconosciuto - Info sul continente non disponibili 23
Totale 59.826
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 46.663
SG - Singapore 2.636
CN - Cina 1.571
DE - Germania 839
UA - Ucraina 779
RU - Federazione Russa 717
BR - Brasile 678
IT - Italia 654
HK - Hong Kong 526
FR - Francia 481
IE - Irlanda 479
VN - Vietnam 471
SE - Svezia 438
GB - Regno Unito 403
FI - Finlandia 272
PL - Polonia 191
KR - Corea 184
IN - India 159
JP - Giappone 152
CA - Canada 138
TR - Turchia 79
NL - Olanda 73
ES - Italia 69
PK - Pakistan 58
ID - Indonesia 54
BE - Belgio 52
AU - Australia 48
AR - Argentina 46
EG - Egitto 44
CH - Svizzera 42
MX - Messico 42
BD - Bangladesh 40
ZA - Sudafrica 35
IQ - Iraq 32
IR - Iran 29
RO - Romania 29
TW - Taiwan 28
UZ - Uzbekistan 28
PH - Filippine 26
AT - Austria 23
KG - Kirghizistan 23
GR - Grecia 20
EU - Europa 19
IL - Israele 19
MY - Malesia 19
AE - Emirati Arabi Uniti 17
EC - Ecuador 17
HU - Ungheria 17
LT - Lituania 17
CZ - Repubblica Ceca 16
MA - Marocco 16
PT - Portogallo 16
SK - Slovacchia (Repubblica Slovacca) 16
TH - Thailandia 15
CL - Cile 13
NG - Nigeria 12
CO - Colombia 11
OM - Oman 11
EE - Estonia 10
KZ - Kazakistan 10
SA - Arabia Saudita 10
DZ - Algeria 9
JO - Giordania 9
PY - Paraguay 9
RS - Serbia 9
TN - Tunisia 9
DK - Danimarca 8
HR - Croazia 8
PE - Perù 8
ET - Etiopia 7
LB - Libano 6
LV - Lettonia 6
NP - Nepal 6
VE - Venezuela 6
CY - Cipro 5
JM - Giamaica 5
NO - Norvegia 5
AZ - Azerbaigian 4
BJ - Benin 4
DO - Repubblica Dominicana 4
KE - Kenya 4
NZ - Nuova Zelanda 4
SN - Senegal 4
BH - Bahrain 3
GH - Ghana 3
HN - Honduras 3
KW - Kuwait 3
MD - Moldavia 3
TT - Trinidad e Tobago 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BA - Bosnia-Erzegovina 2
GA - Gabon 2
NI - Nicaragua 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
A1 - Anonimo 1
AD - Andorra 1
AL - Albania 1
AM - Armenia 1
BB - Barbados 1
Totale 59.806
Salva come PNG Salva come JPEG
Città #
Woodbridge 13.772
Wilmington 10.827
Houston 9.442
Fairfield 1.589
Singapore 1.313
Ann Arbor 1.272
Chandler 1.064
Ashburn 1.024
Jacksonville 681
Seattle 670
San Jose 580
Beijing 560
Cambridge 559
Hong Kong 491
Dublin 476
Medford 384
Dearborn 290
New York 277
Zhengzhou 264
The Dalles 241
Santa Clara 209
Lawrence 181
Los Angeles 166
Rome 138
Kraków 137
Hanoi 134
Dallas 128
Tokyo 122
Ho Chi Minh City 116
Council Bluffs 115
Helsinki 103
Moscow 102
San Diego 97
Lauterbourg 89
Buffalo 87
Mülheim 87
Menlo Park 85
Shanghai 85
Munich 83
Boardman 76
São Paulo 72
Redwood City 62
Milan 51
London 49
Redondo Beach 42
Stockholm 41
Toronto 41
Hefei 39
Nanjing 39
San Mateo 39
Guangzhou 37
Warsaw 37
Brooklyn 35
Montreal 35
Orem 35
Norwalk 33
Phoenix 30
Brussels 29
Jakarta 29
Chicago 28
Frankfurt am Main 28
Jönköping 28
University Park 28
Ankara 27
Denver 27
Falls Church 24
Madrid 24
Nuremberg 24
Verona 24
San Francisco 22
Chennai 21
Columbus 21
Hangzhou 21
Kunming 21
Da Nang 20
Mountain View 20
Palo Alto 20
Turin 20
Haiphong 19
Nanchang 19
Belo Horizonte 18
Dong Ket 18
Atlanta 17
Auburn Hills 17
Johannesburg 17
Boston 16
Curitiba 16
Manchester 16
Poplar 16
Lahore 15
Naples 15
Rio de Janeiro 15
Detroit 14
Duncan 14
Paris 14
Amsterdam 13
Baghdad 13
Fuzhou 13
Mexico City 13
Mumbai 13
Totale 49.680
Salva come PNG Salva come JPEG
Nome #
European S3-guidelines on the systemic treatment of psoriasis vulgaris 1.645
Long-term use of a new topical formulation containing piroxicam 0.8% and sunscreen: efficacy and tolerability on actinic keratosis. A proof of concept study 1.218
Atopic dermatitis and dental manifestations 542
Adalimumab for the treatment of severe psoriasis and psoriatic arthritis 534
AISI: A New Disease Severity Assessment Tool for Hidradenitis Suppurativa 527
Alopecia areata e trachionichia associato a sindrome da insufficienza endocrina plurighiandolare. 506
Kaposi's sarcoma in a patient treated with imatinib mesylate for chronic myeloid leukemia 500
Inflammatory linear verrucous epidermal nevus and epilepsy: remission during valproic acid therapy 499
Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis 495
Clinical aspects of the oral cavity in patients with psoriasis: an initial study and a proposal of a new evaluation method 494
Topical lactoferrin can improve stable psoriatic plaque 490
Superficial and nodular basal cell carcinomas treated with an immune response modifier: a report of seven patients 489
-174G/C IL-6 gene promoter polymorphism predicts therapeutic response to TNF-α blockers 486
Effects of TNF-α and IL-1 β on the activation of genes related to inflammatory, immune responses and cell death in immortalized human HaCat keratinocytes 485
Exclusion of CARD15/NOD2 as a candidate susceptibility gene to psoriasis in the Italian population 483
IL-21 Promotes Skin Recruitment of CD4+ Cells and Drives IFN- -Dependent Epidermal Hyperplasia 479
Apremilast for the treatment of psoriasis. 475
Psoriasis Phenotype in Inflammatory Bowel Disease: A Case-Control Prospective Study 473
Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics 466
Successful treatment of multiple filiform facial warts with imiquimod 5% cream in a patient infected by human immunodeficiency virus 464
Combination of low-dosage cyclosporine and topical pimecrolimus in severe atopic dermatitis with chronic hepatitis B [10] 463
Tazarotene 0-1% gel for psoriasis of the fingernails and toenails: an open, prospective study [9] 463
Treatment of trachyonychia with tazarotene 456
Psoriasis, kaposi's sarcoma and hodgkin's disease in a patient with down's syndrome [2] 456
New topical treatments for psoriasis 455
Tazarotene as alternative topical treatment for onychomycosis 455
Actinic keratosis treated with an immune response modifier: a case report of six patients 454
Golimumab in Patients Affected by Moderate to Severe Psoriatic Arthritis: An Open-Label Study in Thirty-Two Patients Previously Treated with Other Biologics 454
Increased levels of IL-17 in tear fluid of moderate-to-severe psoriatic patients is reduced by adalimumab therapy 452
Effect of anti-tumor necrosis factor-alpha therapies on body mass index in patients with psoriasis 450
Experimental T cells immunotherapy by tumor-loaded ECP-generated dendritic antigen presenting cells 449
Adalimumab in the treatment of plaque-type psoriasis and psoriatic arthritis 446
Lung nodule and facial erythematous plaques: a quiz 443
Trimethoprim-sulfamethoxazole induced erythrodermic psoriasis 440
Alopecia areata e trachionichia associato a sindrome da insufficienza indocrina plurighiandolare 439
Efficacy of short-term cyclosporine treatment to control psoriasis-related events during efalizumab therapy 438
Psoriasis, from pathogenesis to therapeutic strategies: IL-21 as a novel potential therapeutic target 437
Evaluation of clinical and ultrasonographic parameters in psoriatic arthritis patients treated with adalimumab: a retrospective study 437
Continuous treatment of plaque-type psoriasis with etanercept: An observational long-term experience 436
Diagnosis of pigmented skin lesions by dermoscopy: web-based training improves diagnostic performance of non-experts 433
The significance of the development of antinuclear antibodies during infliximab treatment 433
Phrynoderma: a cutaneous sign of an inadequate diet 431
Lack of efficacy of imiquimod in patients with basal cell carcinoma previously treated with rituximab for B cell lymphoma: two case reports 430
Psoriatic arthritis and CARD15 gene polymorphisms: no evidence for association in the Italian population 429
Reply to Scalone and Cortesi: ‘‘Cost-Utility Analysis of Biologic Therapies to Treat Chronic Plaque Psoriasis in Italy: The Importance of Using Updated and Adequate Social Tariffs to Calculate QALYs’’ 429
Topical treatment of basal cell carcinoma with tazarotene: a clinicopathological study on a large series of cases 426
Infliximab therapy induces increased polyclonality of CD4+CD25+ regulatory T cells in psoriasis. 426
Cerebriform plantar hyperplasia: the clinico-pathological hallmark of Proteus syndrome 425
Chronic mucocutaneous candidiasis and alopecia areata as cutaneous expressions of autoimmune polyglandular syndrome type I 424
The impact of biologic therapy in chronic plaque psoriasis from a societal perspective: an analysis based on Italian actual clinical practice 424
Stress reactivity in psoriatic patients 422
Real-life 9-year experience with adalimumab in psoriasis and psoriatic arthritis: results of a single-centre, retrospective study. 422
Local treatment of chronic cutaneous leg ulcers with recombinant human granulocyte-macrophage colony-stimulating factor. 421
Remission and time of resolution of nail psoriasis during infliximab therapy [27] 419
Severe acne successfully treated with etanercept 419
Topical use of calcitriol 3 microg/g ointment in the treatment of mild-to-moderate psoriasis: results from an open-label study 418
Bullous dermatomyositis: A marker of poor prognosis and aggressive internal malignancy? 417
Co-localization of susceptibility loci for psoriasis (PSORS4) and atopic dermatitis (ATOD2) on human chromosome 1q21 417
Dose adjustment of biologic therapies for psoriasis in dermatological practice: a retrospective study 417
Melanoma-associated markers expression in blood: MUC-18 is associated with advanced stages in melanoma patients 416
Characterization of the loricrin (LOR) gene as a positional candidate for the PSORS4 psoriasis susceptibility locus 416
PSORS2 markers are not associated with psoriatic arthritis in the Italian population 414
Treatment of lentigo maligna with tazarotene 0.1% gel 413
Prospective assessment of body weight and body composition changes in patients with psoriasis receiving anti-TNF-α treatment 412
Oral lichen planus: Novel acquisitions in the pathogenesis and treatment 411
Usefulness of QuantiFERON®-TB Gold test in psoriatic patients under treatment with tumour necrosis factor blockers 410
Bowenoid papulosis and invasive Bowen's disease: a multidisciplinary approach 410
High-dose initiation of etanercept in psoriatic arthritis and plaque psoriasis: Efficacy, safety and impact on patients' quality of life 409
Systemic therapy of primary cutaneous B-cell lymphoma, marginal zone type, with rituximab, a chimeric anti-CD20 monoclonal antibody 407
The tumor suppressor activity of IKK alpha in stratified epithelia is exerted in part via the TGF-beta anti proliferative pathway 406
Pharmacodynamic assessment of apremilast for the treatment of moderate-to-severe plaque psoriasis 403
Peculiar clinical and dermoscopic remission pattern following imiquimod therapy of basal cell carcinoma in seborrhoeic areas of the face 401
A 2-year history of an asymptomatic scalp nodule - Cutaneous metastasis from renal cell carcinoma. 401
Erysipeloid cutaneous metastasis from bladder carcinoma 400
Localized morphea treated with imiquimod 5% and dermoscopic assessment of effectiveness 397
What happened after the clinical trials: Long-term safety and efficacy of ustekinumab in daily clinical practice 397
Tofacitinib for the treatment of psoriasis 397
Prevention of Dermatologic Side Effects of Bimatoprost 0.03% Topical Therapy 395
Quality of life of psoriatic patients evaluated by a new psychometric assessment tool: PsoDisk 393
TNF-α antagonists and nail psoriasis: An open, 24-week, prospective cohort study in adult patients with psoriasis 392
Influence and variation of the body mass index in patients treated with etancercept for psoriasis 390
Chronically Sun-damaged Melanomas Express Low Levels of Nuclear Glutathione-S-transferase-π: An Epidemiological and Clinicopathological Study in Italy 389
Cyclosporine: a novel therapeutic approach for Burning Mouth Syndrome 388
The first skin cancer screening day at the Italian parliament: A Euromelanoma initiative 385
Analysis of risk factors in cutaneous malignant melanoma: an italian population-based study 384
Cerebral cavernomas in a family with multiple cutaneous and uterine leiomyomas associated with a new mutation in the fumarate hydratase gene J Invest Dermatol. 2007 Sep;127(9):2271-3. 383
Pyoderma vegetans and ulcerative colitis 382
Zosteriform metastasis of occult bronchogenic carcinoma 381
Immunologic biomarkers for clinical and therapeutic management of psoriasis 381
Severe erytrodermic psoriasis in child twins: From clinical-pathological diagnosis to treatment of choice through genetic analyses: Two case reports 380
Disseminated pagetoid reticulosis presenting as cytotoxic CD4/CD8 double negative cutaneous T-cell lymphoma 378
HIV-associated primary cutaneous anaplastic large cell lymphoma: A clinicopathological subset with more aggressive behavior? Case report and review of the literature 377
Evidence of increased apoptosis and reduced proliferation in basal cell carcinomas treated with tazarotene 375
Ichthyosiform mycosis fungoides: A neoplastic acquired ichthyosis [5] 372
Dermatitis artefacta in sporadic sclerodermoid hepatitis C virus-associated porphyria cutanea tarda 371
Metastatic Crohn's disease of the forehead 370
Small molecules and antibodies for the treatment of psoriasis: A patent review (2010–2015) 369
From patients’ needs to treatment outcomes in psoriasis: Results from the ‘pSORRIDI’ experience 368
Graham Little-Piccardi-Lassueur syndrome: effective treatment with cyclosporin A 366
Serum Protein Profile Changes in Psoriatic Patients Undergoing Treatment With Infliximab 364
Totale 44.808
Salva come PNG Salva come JPEG
Categoria #
all - tutte 139.207
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 139.207
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021796 0 0 0 0 0 0 0 0 0 237 405 154
2021/20222.139 85 272 151 138 59 177 102 113 146 184 141 571
2022/20232.770 258 230 141 407 234 582 181 155 286 27 168 101
2023/20241.153 119 52 81 50 104 290 81 106 23 38 25 184
2024/20254.209 176 802 431 261 112 240 380 210 348 327 476 446
2025/20265.960 560 328 807 602 566 230 843 676 734 614 0 0
Totale 60.621